Abstract
Purpose:
To compare the macular choroidal thickness, ganglion cell complex thickness, peripapillary choroidal thickness and retinal nerve fiber layer thickness among normal, primary open angle glaucoma (POAG) and normal tension glaucoma (NTG) patients using RTVue (Fourier-domain optical coherence tomography; Optovue, Fremont, CA, USA).
Methods:
A retrospective analysis of 32 normal controls, 32 POAG and 52 NTG patients was performed. Choroidal thickness, ganglion cell complex thickness and retinal nerve fiber layer thickness were compared among normal controls, POAG and NTG subjects. Additionally, the factors influencing choroidal thickness (age, axial length, spherical equivalent, central corneal thick-ness, mean deviation, nocturnal dip, blood pressure variability) were analyzed.
Results:
A total of 32 normal controls, 32 POAG and 52 NTG patients were enrolled in this study. Macular and peripapillary cho-roidal thicknesses were significantly thinner in the NTG patients. In NTG subjects, the significant influencing factors associated with macular and peripapillary choroidal thicknesses were age, axial length, nocturnal dip (diastolic blood pressure), diastolic blood pressure variability and ganglion cell complex thickness. In POAG patients, significant influencing factors associated with macular and peripapillary choroidal thicknesses were age and axial length.
Conclusions:
Choroidal thickness was significantly thinner in NTG patients compared with normal controls and POAG patients. Factors influencing choroidal thickness in NTG patients were age, axial length, nocturnal dip (diastolic blood pressure), diastolic blood pressure variability and ganglion cell complex thickness. In POAG patients, significant factors influencing choroidal thick-ness were age and axial length.
References
2. Quigley HA, Nickells RW, Kerrigan LA, et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995; 36:774–86.
3. Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 1994; 39:23–42.
5. Hayreh SS. Blood supply of the optic nerve head and its role in op-tic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol. 1969; 53:721–48.
6. Duijm HF, van den Berg TJ, Greve EL. Choroidal haemodynamics in glaucoma. Br J Ophthalmol. 1997; 81:735–42.
7. Grunwald JE, Piltz J, Hariprasad SM, DuPont J. Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci. 1998; 39:2329–36.
8. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146:496–500.
9. Branchini L, Regatieri CV, Flores-Moreno I, et al. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology. 2012; 119:119–23.
10. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002; 21:359–93.
11. Bayhan HA, Aslan Bayhan S, Can I. Evaluation of the macular choroidal thickness using spectral optical coherence tomography in pseudoexfoliation glaucoma. J Glaucoma. 2014 Aug 18; [Epub ahead of print].
12. Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009; 148:445–50.
13. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009; 147:811–5.
14. Ishikawa H, Stein DM, Wollstein G, et al. Macular segmentation with optical coherence tomography. Invest Ophthalmol Vis Sci. 2005; 46:2012–7.
15. Tan O, Li G, Lu AT, et al. Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthal-mology. 2008; 115:949–56.
16. Collaborative Normal-Tension Glaucoma Study Group. The effec-tiveness of intraocular pressure reduction in the treatment of nor-mal-tension glaucoma. Am J Ophthalmol. 1998; 126:498–505.
17. Wolfs RC, Borger PH, Ramrattan RS, et al. Views on open-Angle glaucoma: definitions and prevalences-The Rotterdam Study. Invest Ophthalmol Vis Sci. 2000; 41:3309–21.
18. Ehrlich JR, Peterson J, Parlitsis G, et al. Peripapillary choroidal thickness in glaucoma measured with optical coherence tomo-graphy. Exp Eye Res. 2011; 92:189–94.
19. Wilkins MR, Fitzke FW, Khaw PT. Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial. Eye (Lond). 2006; 20:98–106.
20. Hirotsu C, Ohta E, Hirose N, Shimizu K. Profile analysis of 24-hours measurements of blood pressure. Biometrics. 2003; 59:907–15.
21. Choi J, Jeong J, Cho HS, Kook MS. Effect of nocturnal blood pres-sure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci. 2006; 47:831–6.
22. Eguchi K, Hoshide S, Schwartz JE, et al. Visit-to-visit and ambula-tory blood pressure variability as predictors of incident car-diovascular events in patients with hypertension. Am J Hypertens. 2012; 25:962–8.
23. Alm A, Bill A. Ocular and optic nerve blood flow at normal and in-creased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determi-nations in brain and some other tissues. Exp Eye Res. 1973; 15:15–29.
24. Hayreh SS. The blood supply of the optic nerve head and the evalu-ation of it-myth and reality. Prog Retin Eye Res. 2001; 20:563–93.
25. Parver LM, Auker C, Carpenter DO. Choroidal blood flow as a heat dissipating mechanism in the macula. Am J Ophthalmol. 1980; 89:641–6.
26. Hirooka K, Tenkumo K, Fujiwara A, et al. Evaluation of peripapil-lary choroidal thickness in patients with normal-tension glaucoma. BMC Ophthalmol. 2012; 12:29.
27. Usui S, Ikuno Y, Miki A, et al. Evaluation of the choroidal thick-ness using high-penetration optical coherence tomography with long wavelength in highly myopic normal-tension glaucoma. Am J Ophthalmol. 2012; 153:10–6.e1.
28. Park HY, Lee NY, Shin HY, Park CK. Analysis of macular and peri-papillary choroidal thickness in glaucoma patients by enhanced depth imaging optical coherence tomography. J Glaucoma. 2014; 23:225–31.
29. Li L, Bian A, Zhou Q, Mao J. Peripapillary choroidal thickness in both eyes of glaucoma patients with unilateral visual field loss. Am J Ophthalmol. 2013; 156:1277–84.
30. Curcio CA, Saunders PL, Younger PW, Malek G. Peripapillary chorioretinal atrophy: Bruch's membrane changes and photo-receptor loss. Ophthalmology. 2000; 107:334–43.
31. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009; 147:811–5.
33. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet. 1978; 1:795–7.
34. Harris A, Topouzis F, Wilson MR, et al. Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study. J Glaucoma. 2013; 22:526–31.
35. Jiang X, Varma R, Wu S, et al. Baseline risk factors that predict the development of open-angle glaucoma in a population: the Los Angeles Latino Eye Study. Ophthalmology. 2012; 119:2245–53.
36. Parati G, Pomidossi G, Ramirez A, et al. Variability of the haemo-dynamic responses to laboratory tests employed in assessment of neural cardiovascular regulation in man. Clin Sci (Lond). 1985; 69:533–40.
37. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375:895–905.
38. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990; 300:5–25.
39. Zeimer R, Asrani S, Zou S, et al. Quantitative detection of glau-comatous damage at the posterior pole by retinal thickness mapping. A pilot study. Ophthalmology. 1998; 105:224–31.
40. Leung CK, Chan WM, Yung WH, et al. Comparison of macular and peripapillary measurements for the detection of glaucoma: an optical coherence tomography study. Ophthalmology. 2005; 112:391–400.
Table 1.
Control | POAG | NTG | p-value | |
---|---|---|---|---|
Age (years) | 60.28 ± 4.28 | 59.32 ± 3.35 | 58.64 ± 2.64 | 0.255∗ |
Male:female | 14:18 | 15:17 | 24:28 | 0.586† |
SE (diopter) | -1.13 ± 1.83 | -1.22 ± 1.77 | -1.23 ± 1.65 | 0.976∗ |
Axial length (mm) | 23.99 ± 1.04 | 23.78 ± 1.02 | 24.01 ± 1.14 | 0.701∗ |
IOP (mm Hg) | 11.67 ± 1.49 | 14.55 ± 2.54§ | 13.84 ± 2.03‡ | 0.000∗ |
MD (dB) | -0.28 ± 0.11 | -4.22 ± 2.47§ | -4.11 ± 1.85‡ | 0.000∗ |
CCT (μ m) | 532.15 ± 21.98 | 535.19 ± 19.15 | 533.27 ± 20.51 | 0.872∗ |
Values are presented as mean ± SD unless otherwise indicated.
POAG = primary open angle glaucoma; NTG = normal tension glaucoma; SE = spherical equivalent; IOP = intraocular pressure; MD = mean deviation; CCT = central corneal thickness.
Table 2.
Control | POAG | NTG | p-value∗ | |
---|---|---|---|---|
Macular choroidal thickness (μ m) | ||||
Average | 240.29 ± 10.17 | 221.77 ± 16.65§ | 210.15 ± 10.30†‡ | 0.000 |
Center | 256.07 ± 35.12 | 232.12 ± 29.17§ | 219.13 ± 25.21† | 0.000 |
Temporal | 226.66 ± 20.31 | 211.10 ± 24.34§ | 201.21 ± 22.20† | 0.001 |
Nasal | 238.15 ± 26.76 | 222.11 ± 21.13 | 210.13 ± 27.06† | 0.001 |
Peripapillary choroidal thickness (μ m) | ||||
Average | 178.32 ± 24.88 | 161.68 ± 19.86§ | 144.18 ± 24.11†‡ | 0.000 |
Superior | 202.54 ± 34.64 | 185.37 ± 25.89 | 169.18 ± 32.27† | 0.001 |
Superonasal | 200.71 ± 34.48 | 188.38 ± 22.12 | 172.28 ± 24.25† | 0.002 |
Nasal | 201.35 ± 28.06 | 183.08 ± 23.50§ | 170.54 ± 26.86† | 0.000 |
Inferonasal | 193.13 ± 23.15 | 166.21 ± 22.93§ | 152.48 ± 21.06† | 0.000 |
Inferior | 165.05 ± 35.10 | 153.84 ± 25.82 | 137.18 ± 31.78† | 0.008 |
Inferotemporal | 216.42 ± 24.89 | 186.16 ± 21.78§ | 154.31 ± 30.12†‡ | 0.000 |
Temporal | 217.96 ± 32.74 | 189.96 ± 37.43§ | 166.92 ± 42.46† | 0.000 |
Superotemporal | 222.50 ± 38.50 | 206.68 ± 32.57 | 183.06 ± 35.12† | 0.001 |
Table 3.
Macular choroidal thickness (μ m) | Peripapillary choroidal thickness (μ m) | |
---|---|---|
Non-dip (systolic) (n = 13) | 221.46 ± 12.59 | 163.51 ± 12.71 |
Dip (systolic) (n = 15) | 224.60 ± 15.53 | 165.85 ± 9.56 |
Over-dip (systolic) (n = 4) | 215.75 ± 4.5 | 163.83 ± 10.79 |
p-value∗ | 0.502 | 0.981 |
Non-dip (diastolic) (n = 11) | 222.73 ± 13.36 | 162.51 ± 13.44 |
Dip (diastolic) (n = 17) | 223.41 ± 14.92 | 164.46 ± 9.19† |
Over-dip (diastolic) (n = 4) | 215.82 ± 13.44 | 164.75 ± 10.84 |
p-value∗ | 0.599 | 0.889 |
Table 4.
Macular choroidal thickness (μ m) | Peripapillary choroidal thickness (μ m) | |
---|---|---|
Non-dip (systolic) (n = 24) | 213.18 ± 11.70 | 155.50 ± 9.67 |
Dip (systolic) (n = 23) | 206.78 ± 14.65 | 145.30 ± 17.24 |
Over-dip (systolic) (n = 5) | 202.91 ± 12.59 | 135.41 ± 9.35† |
p-value∗ | 0.044 | 0.029 |
Non-dip (diastolic) (n = 21) | 213.62 ± 9.80 | 156.70 ± 10.91 |
Dip (diastolic) (n = 26) | 207.44 ± 12.17 | 145.72 ± 16.19 |
Over-dip (diastolic) (n = 5) | 201.57 ± 13.15 | 148.05 ± 14.95† |
p-value∗ | 0.047 | 0.018 |
Table 5.
POAG | Macular choroidal thickness ∗ | Peripapillary choroidal thickness ∗ | ||
---|---|---|---|---|
β ± SE | p-value∗ | β ± SE | p-value∗ | |
Age | -2.024 ± 0.620 | 0.000 | -2.674 ± 1.921 | 0.000 |
Axial length | -0.407 ± 0.895 | 0.029 | -0.912 ± 0.563 | 0.001 |
MAP | 3.385 ± 1.006 | 0.003 | 3.447 ± 1.011 | 0.003 |
Table 6.
NTG | Macular choroidal thickness | Peripapillary choroidal thickness | ||
---|---|---|---|---|
β ± SE | p-value∗ | β ± SE | p-value∗ | |
Age | -3.621 ± 0.668 | 0.000 | -3.463 ± 0.501 | 0.000 |
Axial length | -0.618 ± 2.878 | 0.057 | -0.165 ± 2.140 | 0.126 |
MAP | 2.422 ± 2.957 | 0.148 | 2.950 ± 3.012 | 0.203 |
Diastolic nocturnal dip | -2.605 ± 2.957 | 0.148 | -2.073 ± 1.248 | 0.111 |
Diastolic wSD | -3.020 ± 0.753 | 0.001 | -2.663 ± 2.093 | 0.216 |
Average GCC thickness | 0.092 ± 0.991 | 0.107 | 1.013 ± 0.678 | 0.106 |